Bringing the Oncology Community Together

News & Updates

Latest News & Updates Articles View more >>
FDA Approves Siltuximab for Multicentric Castleman’s Disease
FDA Approves Siltuximab for Multicentric Castleman’s Disease
The FDA has approved the anti-IL-6 chimeric monoclonal antibody siltuximab as a treatment for HIV- and HHV-8-negative patients with multicentric Castleman’s disease.
Novel Immunotherapeutic Safe and Effective in Early-Phase Melanoma Study
Novel Immunotherapeutic Safe and Effective in Early-Phase Melanoma Study
A novel immunotherapeutic known as IMCgp100 induced clinical responses with manageable toxicity in patients with advanced melanoma
Novartis Plans Acquisition of GSK’s Oncology Products
Novartis Plans Acquisition of GSK’s Oncology Products
GSK and Novartis have struck a deal that will move all of GSK's oncology assets to Novartis, all of Novartis' non-flu-related vaccines to GSK, and will result in a joint consumer healthcare venture.
FDA Approves Ramucirumab for Gastric and GEJ Adenocarcinoma
FDA Approves Ramucirumab for Gastric and GEJ Adenocarcinoma
The FDA has approved the VEGFR-2 inhibitor ramucirumab as a treatment for patients with patients with unresectable gastric cancer or gastroesophageal junction adenocarcinoma, based on a significant extension in OS.
Durable T-VEC Responses Fail to Prolong Survival in Updated Analysis
Durable T-VEC Responses Fail to Prolong Survival in Updated Analysis
Talimogene laherparepvec significantly improved durable response rates but failed to extend overall survival in patients with advanced melanoma.
The 2013 European Cancer Congress is a multidisciplinary combination of the 17th ECCO, 38th ESMO, and 32nd ESTRO congresses that is held September 27 to October 1, 2013, in Amsterdam, Netherlands.
View the latest conference coverage >>>
Publications
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.